Clinical trials
Terminated Immune System Diseases trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| miRagen Therapeutics, Inc. | 2 |
| Ariad Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 6 |
| Immunoproliferative Disorders | 3 |
| Lymphatic Diseases | 3 |
| Lymphoproliferative Disorders | 3 |
| Neoplasms | 3 |
| Autoimmune Diseases | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Lymphoma, T-Cell | 2 |
| Lymphoma, T-Cell, Cutaneous | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.